BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10517170)

  • 21. [Lacking effect of timing of surgery in relation to the menstrual cycle on prognosis of breast cancer in premenopausal women].
    Mondini G; Friedman D; De Cian F; Spirito C; Carrabetta S; Costantini M; Sormani MP; Civalleri D
    G Chir; 1997; 18(1-2):7-11. PubMed ID: 9206487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis of patients with breast cancer related to the timing of operation during menstrual cycle: a report of 218 patients].
    Zhang B; Shao Y; Wang C
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):203-7. PubMed ID: 9387255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
    ; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD
    J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Love RR; Duc NB; Dinh NV; Shen TZ; Havighurst TC; Allred DC; DeMets DL
    J Natl Cancer Inst; 2002 May; 94(9):662-9. PubMed ID: 11983754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
    Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Menstrual Cycle Phase on the Prognostic Factors in Patients with Premenopausal Breast Tumors.
    Kundaktepe BP; Durmus S; Papila C; Velidedeoglu M; Gelisgen R; Uzun H
    Chirurgia (Bucur); 2021; 116(2):209-213. PubMed ID: 33950817
    [No Abstract]   [Full Text] [Related]  

  • 27. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
    Tripathy D; Im SA; Colleoni M; Franke F; Bardia A; Harbeck N; Hurvitz SA; Chow L; Sohn J; Lee KS; Campos-Gomez S; Villanueva Vazquez R; Jung KH; Babu KG; Wheatley-Price P; De Laurentiis M; Im YH; Kuemmel S; El-Saghir N; Liu MC; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; Lu YS
    Lancet Oncol; 2018 Jul; 19(7):904-915. PubMed ID: 29804902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the timing of surgery for breast cancer in relation to the menstrual cycle or geomagnetic activity affect prognoses of premenopausal patients?
    Takeda Y; Yanagie H; Yoshizaki I; Eriguchi M
    Biomed Pharmacother; 2003 Oct; 57 Suppl 1():96s-103s. PubMed ID: 14572684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic effect of menstrual cycle on timing of surgery in premenopausal breast cancer patients.
    Liu Y; Wang Y; Zhou L; Yin K; Yin W; Lu J
    Am J Surg; 2015 Sep; 210(3):506-11. PubMed ID: 26066864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of breast surgery in premenopausal breast cancer patients.
    Samuel M; Wai KL; Brennan VK; Yong WS
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD003720. PubMed ID: 21563138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.
    Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; Sahmoud TM; van de Vijver MJ
    J Clin Oncol; 1998 Feb; 16(2):470-9. PubMed ID: 9469330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
    Di Cosimo S; Alimonti A; Ferretti G; Sperduti I; Carlini P; Papaldo P; Fabi A; Gelibter A; Ciccarese M; Giannarelli D; MandalĂ  M; Milella M; Ruggeri EM; Cognetti F
    Ann Oncol; 2004 Jul; 15(7):1065-71. PubMed ID: 15205200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 12. Timing of surgery for breast cancer.
    Fentiman IS
    Int J Clin Pract; 2002 Apr; 56(3):188-90. PubMed ID: 12018824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer.
    Cakir S; Gursel B; Meydan D; Yildiz L
    Jpn J Clin Oncol; 2003 Nov; 33(11):563-9. PubMed ID: 14711980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients.
    Takeda Y; Nonaka Y; Yanagie H; Yoshizaki I; Eriguchi M
    Biomed Pharmacother; 2001; 55 Suppl 1():133s-137s. PubMed ID: 11774860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
    Lambertini M; Boni L; Michelotti A; Gamucci T; Scotto T; Gori S; Giordano M; Garrone O; Levaggi A; Poggio F; Giraudi S; Bighin C; Vecchio C; Sertoli MR; Pronzato P; Del Mastro L;
    JAMA; 2015 Dec 22-29; 314(24):2632-40. PubMed ID: 26720025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival.
    Senie RT; Rosen PP; Rhodes P; Lesser ML
    Ann Intern Med; 1991 Sep; 115(5):337-42. PubMed ID: 1863022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma.
    Wobbes T; Thomas CM; Segers MF; Peer PG; Bruggink ED; Beex LV
    Br J Cancer; 1994 Mar; 69(3):599-600. PubMed ID: 8123495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.